See the DrugPatentWatch profile for Suboxone
The generic name for Suboxone is buprenorphine and naloxone [1].
What is buprenorphine and naloxone used for?
Buprenorphine and naloxone is a medication used to treat opioid use disorder [1]. It is available as a sublingual film and tablet [1].
When did buprenorphine and naloxone become available generically?
Buprenorphine and naloxone became available in generic forms in late 2023 [2].
Who makes generic buprenorphine and naloxone?
Several pharmaceutical companies have launched generic versions of buprenorphine and naloxone, including Teva Pharmaceuticals, Actavis, and Viatris [2].
How does buprenorphine and naloxone work?
Buprenorphine is a partial opioid agonist, meaning it binds to opioid receptors in the brain but with less intensity than full opioid agonists. Naloxone is an opioid antagonist, included to deter misuse by injection [1].
What are the potential side effects of buprenorphine and naloxone?
Common side effects can include headache, nausea, vomiting, sweating, and opioid withdrawal symptoms [1].
Can buprenorphine and naloxone be prescribed to pregnant or breastfeeding individuals?
The U.S. Food and Drug Administration (FDA) has approved buprenorphine and naloxone for use during pregnancy and breastfeeding, under the Medication for Opioid Use Disorder (MOUD) Safe Start program [3].
Where can I find more information on Suboxone and its generics?
Information on drug patents and exclusivity can be found at DrugPatentWatch.com [4].